Loading organizations...
Loading organizations...
Biopharmaceutical company developing immune disorder treatments.
REGiMMUNE has raised $9.2M across 1 funding round.
REGiMMUNE has raised $9.2M in total across 1 funding round.
REGiMMUNE has raised $9.2M in total across 1 funding round.
REGiMMUNE's investors include Japan Asia Investment Corporation, Nippon Venture Capital, KSP, Mitsubishi UFJ Capital, Mitsui, Mizuho Capital, Nissei Insurance, SMBC Venture Capital.
REGiMMUNE has raised $9.2M across 1 funding round. Most recently, it raised $9.2M Series D in February 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 14, 2014 | $9.2M Series D | Japan Asia Investment Corporation, Nippon Venture Capital | KSP, Mitsubishi UFJ Capital, Mitsui, Mizuho Capital, Nissei Insurance, SMBC Venture Capital |